Mode of action assessment for propylene dichloride as a human carcinogen

• Published in: Chemico-biological interactions 2023-09, Vol.382, p.110382-110382, Article 110382
• Main Authors: Kozal, Jordan S., Lynch, Heather N., Klapacz, Joanna, Schoeny, Rita S., Jean, Paul A., Maier, Andrew
• Format: Article
• Language: English
• Subjects: Carcinogenicity; Cholangiocarcinoma; Mechanism; Mode of action; Propylene dichloride; TSCA
• ISSN: 0009-2797; 1872-7786
• DOI: 10.1016/j.cbi.2023.110382

As part of a systematic review of the non-cancer and cancer hazards of propylene dichloride (PDC), with a focus on potential carcinogenicity in workers following inhalation exposures, we determined that a mode of action (MOA)-centric framing of cancer effects was warranted. In our MOA analysis, we systematically reviewed the available mechanistic evidence for PDC-induced carcinogenesis, and we mapped biologically plausible MOA pathways and key events (KEs), as guided by the International Programme on Chemical Safety (IPCS)-MOA framework. For the identified pathways and KEs, biological concordance, essentiality of KEs, concordance of empirical observations among KEs, consistency, and analogy were evaluated. The results of this analysis indicate that multiple biologically plausible pathways may contribute to the cancer MOA for PDC, but that the relevant pathways vary by exposure route and level, tissue type, and species; further, more than one pathway may occur concurrently at high exposure levels. While several important data gaps exist, evidence from in vitro mechanistic studies, in vivo experimental animal studies, and ex vivo human tumor tissue analyses indicates that the predominant MOA pathway likely involves saturation of cytochrome p450 2E1 (CYP2E1)-glutathione (GSH) detoxification (molecular initiating event; MIE), accumulation of CYP2E1-oxidative metabolites, cytotoxicity, chronic tissue damage and inflammation, and ultimately tumor formation. Tumors may occur through several subsets of inflammatory KEs, including inflammation-induced aberrant expression of activation-induced cytidine deaminase (AID), which causes DNA strand breaks and mutations and can lead to tumors with a characteristic mutational signature found in occupational cholangiocarcinoma. Dose concordance analysis showed that low-dose mutagenicity (from any pathway) is not a driving MOA, and that prevention of target tissue damage and inflammation (associated with saturation of CYP2E1-GSH detoxification) is expected to also prevent the cascade of processes responsible for tumor formation. •Evaluated potential cancer modes of action (MOAs) for propylene dichloride (PDC).•Multiple biologically plausible pathways may contribute to overarching cancer MOA.•Relevant MOA pathways may vary with exposure and overlap at high exposure levels.•Dose concordance analysis revealed low-dose genotoxicity is not a driving MOA.•Primary MOA for human cholangiocarcinoma appears to be secondary to inflammat